Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiffany Richards

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of the Advanced Practitioner in Oncology|June 4, 2021
Diagnosis and Treatment of AL and ATTR AmyloidosisBeth Faiman, Tiffany Richards
Medical Oncology (Northwood, London, England)|March 10, 2010
Advances in treatment for relapses and refractory multiple myelomaTiffany Richards, Donna Weber
Journal of the Advanced Practitioner in Oncology|August 5, 2014
Innovative agents in multiple myelomaBeth Faiman, Tiffany Richards
Journal of the Advanced Practitioner in Oncology|August 8, 2022
A Focus on Waldenström Macroglobulinemia and AL AmyloidosisRebecca Lu, Tiffany Richards
Journal of the Advanced Practitioner in Oncology|August 8, 2022
A Focus on CAR T-Cell Therapy and Bispecific Antibodies in Multiple MyelomaDonna Catamero, Tiffany Richards, Beth Faiman
Seminars in Oncology Nursing|July 8, 2017
Strategies for Selecting the Optimal Treatment in Newly Diagnosed Multiple Myeloma PatientsMary Steinbach, Tiffany Richards, Beth Faiman
Biology of Reproduction|December 19, 2009
Rescue of postcompaction-stage mouse embryo development from hypertonicity by amino acid transporter substrates that may function as organic osmolytesTiffany Richards, Fang Wang, Lin Liu, et al.
Clinical Journal of Oncology Nursing|February 3, 2012
Survey of experiences of an e-mentorship program: Part IIBeth Faiman, Teresa S Miceli, Tiffany Richards, et al.
Biology of Reproduction|September 24, 2004
Similar effects of osmolarity, glucose, and phosphate on cleavage past the 2-cell stage in mouse embryos from outbred and F1 hybrid femalesTimin Hadi, Mary-Anne Hammer, Carolyn Algire, et al.
Journal of the Advanced Practitioner in Oncology|June 14, 2023
Management of Ocular Toxicity in Patients Receiving Belantamab MafodotinRebecca Lu, Ashley Morphey, Felicia Diaz, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of the Advanced Practitioner in Oncology|June 4, 2021
Diagnosis and Treatment of AL and ATTR AmyloidosisBeth Faiman, Tiffany Richards
Medical Oncology (Northwood, London, England)|March 10, 2010
Advances in treatment for relapses and refractory multiple myelomaTiffany Richards, Donna Weber
Journal of the Advanced Practitioner in Oncology|August 5, 2014
Innovative agents in multiple myelomaBeth Faiman, Tiffany Richards
Journal of the Advanced Practitioner in Oncology|August 8, 2022
A Focus on Waldenström Macroglobulinemia and AL AmyloidosisRebecca Lu, Tiffany Richards
Journal of the Advanced Practitioner in Oncology|August 8, 2022
A Focus on CAR T-Cell Therapy and Bispecific Antibodies in Multiple MyelomaDonna Catamero, Tiffany Richards, Beth Faiman
Seminars in Oncology Nursing|July 8, 2017
Strategies for Selecting the Optimal Treatment in Newly Diagnosed Multiple Myeloma PatientsMary Steinbach, Tiffany Richards, Beth Faiman
Biology of Reproduction|December 19, 2009
Rescue of postcompaction-stage mouse embryo development from hypertonicity by amino acid transporter substrates that may function as organic osmolytesTiffany Richards, Fang Wang, Lin Liu, et al.
Clinical Journal of Oncology Nursing|February 3, 2012
Survey of experiences of an e-mentorship program: Part IIBeth Faiman, Teresa S Miceli, Tiffany Richards, et al.
Biology of Reproduction|September 24, 2004
Similar effects of osmolarity, glucose, and phosphate on cleavage past the 2-cell stage in mouse embryos from outbred and F1 hybrid femalesTimin Hadi, Mary-Anne Hammer, Carolyn Algire, et al.
Journal of the Advanced Practitioner in Oncology|June 14, 2023
Management of Ocular Toxicity in Patients Receiving Belantamab MafodotinRebecca Lu, Ashley Morphey, Felicia Diaz, et al.
Pageof 2